Brief: Insilico Medicine Cayman Announces Drug Discovery Collaboration With Takeda Worth Up To $600 Million
02/07/2026 01:31
BRIEF-Insilico Medicine Cayman Announces Drug Discovery Collaboration With Takeda Worth Up To $600 Million July 2 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:
VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE AND TAKEDA ACHIEVED STRATEGIC AI-POWERED DRUG DISCOVERY COLLABORATION WORTH UP TO USD600 MILLION
TAKEDA GRANTED EXCLUSIVE WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE COLLABORATION THERAPEUTICS
DEAL VALUE UP TO USD600 MILLION INCLUDING USD60 MILLION IN UPFRONT AND NEAR-TERM PAYMENTS
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7